GlassScriptPhysician profile
Peter Kuan-Teh Lee
NPI 1891939708
$13,312.19
in general payments reported to CMS, 2019-2025
20 companies · $1,388 in 2025
The $1,388 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $14.13 · 2021: $128 · 2022: $4,053 · 2023: $7,335 · 2024: $175 · 2025: $1,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Travel and Lodging: $1,892 · Food and Beverage: $990 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Travel and Lodging | $1,891.75 |
| Food and Beverage | $989.90 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,488.28 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $175.97 | 2019-2021 | |
| Coloplast Corp | $136.34 | 2025 | |
| Integra Lifesciences Corporation | $99.21 | 2019 | |
| Solventum Corporation | $57.50 | 2024-2025 | V.A.C. Dermatac, Promogran Prisma, Activ.A.C. |
| Blueprint Medicines Corporation | $34.52 | 2023-2024 | Ayvakit |
| Pfizer INC. | $34.32 | 2024-2025 | |
| Thd America, INC. | $32.93 | 2021 | |
| Novartis Pharmaceuticals Corporation | $28.38 | 2025 | |
| Beone Medicines USA, INC. | $28.10 | 2025 | Tevimbra, Brukinsa |
| Beigene USA, INC. | $27.60 | 2024 | Brukinsa |
| Vertex Pharmaceuticals Incorporated | $24.55 | 2024 | |
| Dentsply Sirona INC | $23.00 | 2021 | |
| Incyte Corporation | $22.67 | 2024 | Jakafi |
| Genzyme Corporation | $21.74 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $16.80 | 2024 | Tisseel |
| Convatec INC. | $15.94 | 2021 | |
| Seagen INC. | $15.54 | 2023 | Adcetris |
| Medtronic, INC. | $14.67 | 2023 | Signia |
| Baudax Bio INC. | $14.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.